VANS Electroengineerings
Final demand is exceptionally strong across NII and retail, with strong GMP momentum. SME liquidity risk remains material.
OPEN FULL ANALYSIS →A structured comparison of current and recently listed IPOs across demand, GMP sentiment, offer terms, internal research score and risk context.
| Metric | VANS ElectroengineeringsSME · Listing 07 Oct | SRIT IndiaMainboard · Listed 06 Oct | R.K. Fashion AccessoriesSME · Live issue |
|---|---|---|---|
| Angel Research Score | 8.6High Interest | 7.6Positive | 5.4Watchlist |
| Issue / Upper Price | ₹118 | ₹130 | ₹82 |
| Issue Size | Refer offer document | ₹218.4 Cr | ₹34.99 Cr |
| Total Subscription | 628.73×Final | 125.16×Final | 0.40×Day 1 close |
| QIB | 281.65× | 91.84× | 14.11× |
| NII | 1,031.87× | 312.99× | 0.62× |
| Retail | 686.32× | 63.70× | 0.01× |
| Latest / Final GMP | +₹103Unofficial | ₹62Last recorded before listing | ₹—No established reliable quote |
| Indicative / Actual Price | ₹221GMP-implied | ₹148Actual listing price | — |
| Business / Financial Quality | 6.8 / 10 | 7.0 / 10 | 6.2 / 10 |
| Risk Profile | HigherSME liquidity & volatility | ModerateMainboard; sentiment mismatch risk | HigherSME + early demand uncertainty |
| Valuation Context | Verify RHP peer multiples | Verify RHP peer multiples | Verify RHP peer multiples |
Final demand is exceptionally strong across NII and retail, with strong GMP momentum. SME liquidity risk remains material.
OPEN FULL ANALYSIS →The actual ₹148 listing allows direct comparison between a strong pre-listing GMP signal and the realized opening premium.
OPEN LISTING REVIEW →Early demand is mixed and the absence of a reliable GMP makes the issue more dependent on offer-document quality and later subscription behavior.
OPEN LIVE MONITOR →Join the IPO Desk for GMP, subscription and score alerts with source tracking.
Angel Research Score is an internal comparative framework. GMP is unofficial and unregulated. Subscription and listing data should be checked against exchange and issuer disclosures before use. Nothing on this page is an investment recommendation.